IPSEN SA ADR Current Ratio 2016-2019 | IPSEY

IPSEN SA ADR current ratio from 2016 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
IPSEN SA ADR Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $1.37B $1.88B 0.73
2018-12-31 $1.40B $1.13B 1.24
2017-12-31 $1.15B $1.07B 1.08
2017-06-30 $1.02B $1.01B 1.00
2016-12-31 $1.16B $0.62B 1.87
2016-06-30 $1.09B $0.49B 2.23
2015-12-31 $0.90B $0.51B 1.76
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.511B $3.016B
Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.415B 32.06
Takeda Pharmaceutical (TAK) Japan $49.277B 8.64
Astellas Pharma (ALPMY) Japan $30.146B 15.06
Eisai (ESALY) Japan $21.608B 40.25
UCB SA (UCBJF) Belgium $16.296B 0.00
Grifols, S.A (GRFS) Spain $14.164B 17.61
Merck (MKGAF) Germany $13.525B 17.74
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.453B 234.85
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.387B 30.39
Ionis Pharmaceuticals (IONS) United States $6.712B 20.34
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.591B 6.82
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.593B 0.00
United Therapeutics (UTHR) United States $4.260B 0.00
Hypermarcas (HYPMY) Brazil $3.661B 11.14
Evotec AG (EVTCY) Germany $3.485B 56.21
Nektar Therapeutics (NKTR) United States $3.207B 0.00
FibroGen (FGEN) United States $3.083B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.945B 54.66
PTC Therapeutics (PTCT) United States $2.664B 0.00
ChemoCentryx (CCXI) United States $2.441B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.391B 9.67
Xencor (XNCR) United States $1.736B 70.88
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.651B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.634B 19.86
Sage Therapeutics (SAGE) United States $1.531B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.453B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.417B 38.75
Corcept Therapeutics (CORT) United States $1.341B 15.00
Karyopharm Therapeutics (KPTI) United States $1.312B 0.00
USANA Health Sciences (USNA) United States $1.249B 13.11
Zogenix (ZGNX) United States $1.161B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Heron Therapeutics (HRTX) United States $1.056B 0.00
Akebia Therapeutics (AKBA) United States $1.034B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 31.29
Esperion Therapeutics (ESPR) United States $0.935B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.919B 12.79
Endo (ENDP) Ireland $0.830B 1.53
Translate Bio (TBIO) United States $0.689B 0.00
Tilray (TLRY) Canada $0.688B 0.00
Molecular Templates (MTEM) United States $0.643B 0.00
Aerie Pharmaceuticals (AERI) United States $0.626B 0.00
ImmunoGen (IMGN) United States $0.619B 0.00
Radius Health (RDUS) United States $0.606B 0.00
Collegium Pharmaceutical (COLL) United States $0.580B 0.00
Portola Pharmaceuticals (PTLA) United States $0.568B 0.00
Indivior (INVVY) United States $0.464B 2.76
Catalyst Pharmaceuticals (CPRX) United States $0.401B 13.38
Corbus Pharmaceuticals Holdings (CRBP) United States $0.399B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.398B 16.35
Siga Technologies (SIGA) United States $0.396B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.380B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.371B 0.00
Organogenesis Holdings (ORGO) United States $0.357B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.327B 0.00
Trillium Therapeutics (TRIL) Canada $0.323B 0.00
Flexion Therapeutics (FLXN) United States $0.317B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Lannett Co Inc (LCI) United States $0.304B 4.89
Harpoon Therapeutics (HARP) United States $0.294B 0.00
DURECT (DRRX) United States $0.294B 0.00
Calithera Biosciences (CALA) United States $0.294B 0.00
TherapeuticsMD (TXMD) United States $0.291B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.279B 0.00
Concert Pharmaceuticals (CNCE) United States $0.269B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.261B 0.00
Ocular Therapeutix (OCUL) United States $0.260B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.258B 0.00
CASI Pharmaceuticals (CASI) United States $0.207B 0.00
OptiNose (OPTN) United States $0.197B 0.00
Recro Pharma (REPH) United States $0.187B 0.00
Rafael Holdings (RFL) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 3.06
Nature's Sunshine Products (NATR) United States $0.162B 20.24
PROFOUND MEDICL (PROF) Canada $0.157B 0.00
MEI Pharma (MEIP) United States $0.153B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.138B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.120B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.113B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.102B 0.00
Redhill Biopharma (RDHL) Israel $0.096B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
IMV INC (IMV) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.087B 0.00
Champions Oncology (CSBR) United States $0.083B 0.00
Xeris Pharmaceuticals (XERS) United States $0.082B 0.00
Aquestive Therapeutics (AQST) United States $0.076B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.076B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.074B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Biomerica (BMRA) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.066B 0.00
Otonomy (OTIC) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.055B 17.29
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Infinity Pharmaceuticals (INFI) United States $0.048B 0.00
Nivalis Therapeutics (ALPN) United States $0.046B 0.00
PharmAthene (ALT) United States $0.046B 0.00
GTx (ONCT) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 20.34
Onconova Therapeutics (ONTX) United States $0.043B 0.00
MediWound (MDWD) Israel $0.043B 0.00
Aclaris Therapeutics (ACRS) United States $0.042B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 134.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.037B 0.00
IsoRay (ISR) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Mannatechorporated (MTEX) United States $0.026B 8.04
Lipocine (LPCN) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Novan (NOVN) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Vical (BBI) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00